DR Habeerbullah Life Sciences has informed that the meeting of the Board of Directors of the Company is scheduled on 11/02/2019, to consider and approve Un-Audited Standalone Financial Results and Limited Review Report for the Quarter III ended 31St December, 2018; and any other business with the permission of chair.
The above information is a part of company’s filings submitted to BSE.